Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
600211:CHShanghai

Tibet Rhodiola Pharmaceutical Holding Co

COMPANY INFO
37.80CNY
+0.63+1.69%
Market Closed
As of 08/16/2019 EDT
Open
36.99
Prev Close
37.17
Volume
6,472,340
Market Cap
6.790B
Day Range
36.7139.69
52 Week Range
24.6544.30
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio28.02
Bloomberg (BEst) P/E Ratio18.9950
Bloomberg (BEst) PEG Ratio--
Shares Outstanding179.62M
Price to Book Ratio2.9615
Price to Sales Ratio5.7104
1 Year Return23.77%
30 Day Avg Volume1,196,902
EPS1.35
Bloomberg (BEst) EPS Curr Yr1.9900
Dividend0.98%
Last Dividend Reported0.37
Earnings Announcement for Period Ending Q3/2019:10/25/2019

Compare
1-Day Performance

0+2%
0+2%
Equity
600211:CH
+1.69%
Sponsored By

About Tibet Rhodiola Pharmaceutical Holding Co

Tibet Rhodiola Pharmaceutical Holding Co. develops, manufactures, and markets Tibet medicines. The Company's products include Rhodiola capsules, Rhodiola pellets, and other related medicines.
Address
93 Bejing Center Road Lhasa, 850000 China
Phone
86-891-6835809
Website
www.xzyy.cn

Income Statement

Quarterly
Annual
;
Q2 2019 (Millions CNY)
  • Revenue
    321.77
  • Net Income
    86.63
  • Profit Margin
    26.92%

Balance Sheet

Quarterly
Annual
Q2 2019 (Millions CNY)
  • Total Assets
    2,584.99
  • Total Liabilities
    317.90
  • Debt to Assets
    0.00%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions CNY)
  • Operating
    233.05
  • Investing
    -21.50
  • Financing
    -149.75